Literature DB >> 31401203

Investigating the impact of influenza on excess mortality in all ages in Italy during recent seasons (2013/14-2016/17 seasons).

Aldo Rosano1, Antonino Bella2, Francesco Gesualdo3, Anna Acampora4, Patrizio Pezzotti2, Stefano Marchetti5, Walter Ricciardi6, Caterina Rizzo7.   

Abstract

OBJECTIVES: In recent years, Italy has been registering peaks in death rates, particularly among the elderly during the winter season. Influenza epidemics have been indicated as one of the potential determinants of such an excess. The objective of our study was to estimate the influenza-attributable contribution to excess mortality during the influenza seasons from 2013/14 to 2016/17 in Italy.
METHODS: We used the EuroMomo and the FluMomo methods to estimate the annual trend of influenza-attributable excess death rate by age group. Population data were provided by the National Institute of Statistics, data on influenza like illness and confirmed influenza cases were provided by the National Institutes of Health. As an indicator of weekly influenza activity (IA) we adopted the Goldstein index, which is the product of the percentage of patients seen with influenza-like illness (ILI) and percentage of influenza-positive specimens, in a given week.
RESULTS: We estimated excess deaths of 7,027, 20,259, 15,801 and 24,981 attributable to influenza epidemics in the 2013/14, 2014/15, 2015/16 and 2016/17, respectively, using the Goldstein index. The average annual mortality excess rate per 100,000 ranged from 11.6 to 41.2 with most of the influenza-associated deaths per year registered among the elderly. However children less than 5 years old also reported a relevant influenza attributable excess death rate in the 2014/15 and 2016/17 seasons (1.05/100,000 and 1.54/100,000 respectively).
CONCLUSIONS: Over 68,000 deaths were attributable to influenza epidemics in the study period. The observed excess of deaths is not completely unexpected, given the high number of fragile very old subjects living in Italy. In conclusion, the unpredictability of the influenza virus continues to present a major challenge to health professionals and policy makers. Nonetheless, vaccination remains the most effective means for reducing the burden of influenza, and efforts to increase vaccine coverage and the introduction of new vaccine strategies (such as vaccinating healthy children) should be considered to reduce the influenza attributable excess mortality experienced in Italy and in Europe in the last seasons.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Flu; Italy; Mortality; Vaccination

Mesh:

Substances:

Year:  2019        PMID: 31401203     DOI: 10.1016/j.ijid.2019.08.003

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  25 in total

1.  Estimates of mortality associated with seasonal influenza for the European Union from the GLaMOR project.

Authors:  John Paget; A Danielle Iuliano; Robert J Taylor; Lone Simonsen; Cecile Viboud; Peter Spreeuwenberg
Journal:  Vaccine       Date:  2022-01-31       Impact factor: 3.641

2.  [Health Technology Assessment (HTA) of the introduction of influenza vaccination for Italian children with Fluenz Tetra®].

Authors:  Sara Boccalini; Elena Pariani; Giovanna Elisa Calabrò; Chiara DE Waure; Donatella Panatto; Daniela Amicizia; Piero Luigi Lai; Caterina Rizzo; Emanuele Amodio; Francesco Vitale; Alessandra Casuccio; Maria Luisa DI Pietro; Cristina Galli; Laura Bubba; Laura Pellegrinelli; Leonardo Villani; Floriana D'Ambrosio; Marta Caminiti; Elisa Lorenzini; Paola Fioretti; Rosanna Tindara Micale; Davide Frumento; Elisa Cantova; Flavio Parente; Giacomo Trento; Sara Sottile; Andrea Pugliese; Massimiliano Alberto Biamonte; Duccio Giorgetti; Marco Menicacci; Antonio D'Anna; Claudia Ammoscato; Emanuele LA Gatta; Angela Bechini; Paolo Bonanni
Journal:  J Prev Med Hyg       Date:  2021-09-10

3.  Countries with high deaths due to flu and tuberculosis demonstrate lower COVID-19 mortality: roles of vaccinations.

Authors:  Sanmoy Pathak; Mohit Kumar Jolly; Dipankar Nandi
Journal:  Hum Vaccin Immunother       Date:  2021-04-15       Impact factor: 3.452

4.  Analysis of Emergency Department Visits and Hospital Activity during Influenza Season, COVID-19 Epidemic, and Lockdown Periods in View of Managing a Future Disaster Risk: A Multicenter Observational Study.

Authors:  Enrique Casalino; Christophe Choquet; Donia Bouzid; Olivier Peyrony; Sonja Curac; Eric Revue; Jean-Paul Fontaine; Patrick Plaisance; Anthony Chauvin; Daniel Aiham Ghazali
Journal:  Int J Environ Res Public Health       Date:  2020-11-10       Impact factor: 3.390

5.  Attitudes and Beliefs on Influenza Vaccination during the COVID-19 Pandemic: Results from a Representative Italian Survey.

Authors:  Alexander Domnich; Maura Cambiaggi; Alessandro Vasco; Luca Maraniello; Filippo Ansaldi; Vincenzo Baldo; Paolo Bonanni; Giovanna Elisa Calabrò; Claudio Costantino; Chiara de Waure; Giovanni Gabutti; Vincenzo Restivo; Caterina Rizzo; Francesco Vitale; Riccardo Grassi
Journal:  Vaccines (Basel)       Date:  2020-11-30

6.  Population-level COVID-19 mortality risk for non-elderly individuals overall and for non-elderly individuals without underlying diseases in pandemic epicenters.

Authors:  John P A Ioannidis; Cathrine Axfors; Despina G Contopoulos-Ioannidis
Journal:  Environ Res       Date:  2020-07-01       Impact factor: 6.498

7.  Simultaneous circulation of COVID-19 and flu in Italy: Potential combined effects on the risk of death?

Authors:  Alessandro Capone
Journal:  Int J Infect Dis       Date:  2020-08-05       Impact factor: 3.623

8.  Flu Vaccination Attitudes, Behaviours, and Knowledge among Health Workers.

Authors:  Antonella Arghittu; Marco Dettori; Antonio Azara; Davide Gentili; Antonello Serra; Bruno Contu; Paolo Castiglia
Journal:  Int J Environ Res Public Health       Date:  2020-05-03       Impact factor: 3.390

Review 9.  Answering 20 more questions on COVID-19 (March-April 2020).

Authors:  Igor Rudan
Journal:  J Glob Health       Date:  2020-12       Impact factor: 4.413

10.  On the relationship between BCG coverage and national COVID-19 outcome: could 'heterologous' herd immunity explain why some countries are better off?

Authors:  M Lerm
Journal:  J Intern Med       Date:  2020-12       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.